Copper peptides are among the most well-researched peptides in dermatology and cosmetic science. Two names dominate the conversation: GHK-Cu (Copper Tripeptide-1) and AHK-Cu (Copper Tripeptide-3). Both are short-chain peptides bound to a copper ion, and both have published research supporting their use — but they are not interchangeable.
GHK-Cu is a naturally occurring peptide with decades of research behind it, primarily studied for skin rejuvenation, wound healing, and broad tissue remodeling. AHK-Cu is a synthetic peptide engineered specifically to target hair follicle cells. Understanding the difference matters if you are choosing between them for a skin, hair, or healing protocol.
This guide breaks down what each copper peptide does, how they work at the molecular level, how they are administered, and which one makes sense for your goals.
What Is GHK-Cu?
GHK-Cu stands for glycyl-L-histidyl-L-lysine copper(II) — a tripeptide complexed with a copper ion, also known commercially as Copper Tripeptide-1. It was first isolated from human plasma in the 1970s by Dr. Loren Pickart, who observed that older plasma lost its ability to stimulate liver cell growth compared to younger plasma. The active factor turned out to be this small copper-binding peptide.
GHK-Cu occurs naturally in human blood, saliva, and urine. Plasma concentrations are approximately 200 ng/mL at age 20 and decline to roughly 80 ng/mL by age 60 — a 60% drop that correlates with visible signs of aging in skin and slower wound healing.
Structurally, GHK-Cu is classified as a matrikine: a fragment of the extracellular matrix (ECM) that signals cells to remodel and repair surrounding tissue. This is the key to understanding why GHK-Cu has such a broad range of effects — it does not target a single pathway. Instead, it modulates gene expression across thousands of genes involved in tissue maintenance.
Key mechanisms of GHK-Cu:
- Collagen synthesis — Stimulates production of collagen types I, III, and IV, along with decorin, elastin, and glycosaminoglycans (GAGs). These are the structural proteins that maintain skin firmness and elasticity.
- Metalloproteinase regulation — Modulates matrix metalloproteinases (MMPs) and their inhibitors (TIMPs), balancing tissue breakdown with new tissue formation rather than simply suppressing one side.
- Antioxidant defense — Upregulates superoxide dismutase (SOD) and activates the Nrf2 antioxidant pathway, reducing oxidative damage that accelerates skin aging.
- Anti-inflammatory signaling — Suppresses pro-inflammatory cytokines via NF-kB pathway modulation and influences TGF-beta signaling, reducing chronic low-grade inflammation in aging tissue.
- Stem cell recruitment — Research suggests GHK-Cu attracts mesenchymal stem cells to sites of tissue damage, supporting regeneration rather than scar formation.
Gene expression studies have identified over 4,000 genes that GHK-Cu influences — roughly 6% of the human genome. This is an unusually broad profile for a single peptide and explains why GHK-Cu appears in research on skin aging, wound healing, hair health, lung tissue repair, and even bone remodeling.
For more detail on dosing and protocols, see our GHK-Cu dosage guide.
What Is AHK-Cu?
AHK-Cu stands for alanyl-L-histidyl-L-lysine copper(II) — also known as Copper Tripeptide-3. The difference from GHK-Cu is a single amino acid substitution: alanine replaces glycine at the first position. This seemingly minor change produces a peptide with a meaningfully different biological profile.
Unlike GHK-Cu, AHK-Cu does not occur naturally in the human body. It is entirely synthetic, designed in the laboratory to optimize signaling to a specific cell type: dermal papilla cells (DPCs). These are the specialized fibroblasts at the base of each hair follicle that regulate the hair growth cycle — they determine when a follicle enters the growth phase (anagen), how long it stays there, and when it transitions to rest (catagen/telogen).
The foundational research on AHK-Cu comes from Pyo et al. (2007), published in the Journal of Peptide Science. This study demonstrated that the tripeptide-copper complex stimulated human hair follicle elongation ex vivo and increased dermal papilla cell proliferation in vitro at concentrations as low as 10⁻¹² to 10⁻⁹ M.
Key mechanisms of AHK-Cu:
- Dermal papilla cell proliferation — Directly stimulates the growth and division of DPCs, the master regulators of the hair follicle cycle. More active DPCs means stronger signaling for follicles to remain in the growth phase.
- VEGF upregulation — Increases vascular endothelial growth factor production by dermal fibroblasts, improving blood supply to hair follicles. Better vascularization delivers more nutrients and oxygen to the follicle during active growth.
- TGF-beta1 suppression — Decreases secretion of transforming growth factor-beta1, a cytokine that promotes catagen (the regression phase of hair growth). By reducing TGF-beta1, AHK-Cu helps prevent premature transition out of the growth phase.
- Anti-apoptotic effects — Elevates the Bcl-2/Bax ratio in follicle cells and reduces caspase-3 activity, protecting dermal papilla cells from programmed cell death. This is significant because DPC apoptosis is a driver of follicle miniaturization in androgenetic alopecia.
- Anagen phase extension — The combined effect of these mechanisms is to prolong the active growth phase of hair, resulting in thicker, longer individual hairs and greater overall hair density over time.
Where GHK-Cu is a generalist that remodels tissue broadly, AHK-Cu is a specialist engineered to address a specific problem: declining hair follicle function.
How They Work: Mechanism Comparison
Both GHK-Cu and AHK-Cu are copper-peptide complexes that share the histidyl-lysine motif responsible for copper binding. Both modulate growth factors and have antioxidant properties. But the scope of their activity is fundamentally different.
GHK-Cu operates as a systemic tissue remodeler. It influences thousands of genes across multiple tissue types — skin, connective tissue, lung, bone. It does not target a single cell type or pathway. Instead, it acts as a broad restoration signal, pushing aging or damaged tissue back toward a younger gene expression profile. Think of it as a general contractor for tissue maintenance.
AHK-Cu operates as a targeted follicle signal. Its effects are concentrated on dermal papilla cells and the hair growth cycle. It increases VEGF for follicle blood supply, suppresses TGF-beta1 to prevent premature catagen, and protects DPCs from apoptosis. Think of it as a specialist hired to solve one specific problem.
This distinction matters for choosing between them. If your goal involves skin quality, wound healing, or general anti-aging, GHK-Cu's broad mechanism is what you want. If your goal is specifically hair growth or preventing hair thinning, AHK-Cu's targeted mechanism is more directly relevant.
GHK-Cu Benefits
GHK-Cu has the most extensive research base of any copper peptide. Its benefits span multiple systems:
Skin rejuvenation — Human studies show topical GHK-Cu improves skin firmness, reduces fine lines and wrinkle depth, increases skin density and thickness, and improves overall skin clarity. These effects are driven by increased collagen and elastin production along with improved GAG content in the dermal layer.
Wound healing and tissue repair — GHK-Cu accelerates wound closure, reduces scar formation, and promotes organized collagen deposition rather than disorganized scar tissue. It attracts immune cells and fibroblasts to wound sites and modulates the inflammatory response to favor healing over chronic inflammation.
Anti-inflammatory effects — By suppressing NF-kB signaling and modulating cytokine profiles, GHK-Cu reduces the chronic low-grade inflammation (sometimes called "inflammaging") that contributes to skin aging, joint degradation, and tissue breakdown.
Hair support (indirect) — GHK-Cu supports scalp health through improved blood flow, reduced inflammation, and enhanced collagen production in the scalp dermis. Some research suggests it may increase follicle size. However, its hair-specific effects are indirect compared to AHK-Cu's targeted follicle signaling.
Systemic benefits via injection — When administered subcutaneously, GHK-Cu's tissue-remodeling effects extend beyond the skin. Note: injectable GHK-Cu is currently classified as FDA Category 2, meaning compounding pharmacies cannot legally produce it. Topical GHK-Cu was never restricted and remains widely available over the counter.
AHK-Cu Benefits
AHK-Cu's research base is smaller but more focused. Its benefits center on the hair follicle:
Hair growth stimulation — The primary indication for AHK-Cu. Published research demonstrates that it stimulates hair follicle elongation and increases dermal papilla cell proliferation — the two most direct measures of hair growth activity at the cellular level.
Dermal papilla cell protection — By elevating the Bcl-2/Bax ratio and reducing caspase-3 activity, AHK-Cu protects the cells that control the hair growth cycle from programmed death. This is relevant for androgenetic alopecia, where DPC apoptosis drives follicle miniaturization.
Anagen phase extension — Through TGF-beta1 suppression and DPC stimulation, AHK-Cu helps hair follicles stay in the active growth phase longer. Longer anagen means longer, thicker individual hairs before the follicle cycles to rest.
Scalp health — AHK-Cu's antioxidant properties and VEGF upregulation improve the follicular microenvironment — better blood supply, less oxidative stress, healthier conditions for hair production.
Some skin benefits — Like GHK-Cu, AHK-Cu can stimulate collagen production and has antioxidant effects on skin. However, it has been studied far less extensively for skin-specific outcomes, and GHK-Cu remains the stronger choice for skin rejuvenation.
Administration: How They Are Used
GHK-Cu
GHK-Cu is available in two primary forms:
Topical (most common): Applied as a serum or cream at concentrations of 1-2%, typically once or twice daily. Topical GHK-Cu is widely available over the counter in skincare products. The peptide's small molecular weight allows reasonable penetration through the skin barrier. Most anti-aging and wound-healing protocols use the topical route.
Injectable (subcutaneous): Administered at 1-2 mg daily via subcutaneous injection, typically in cycles of 4-8 weeks. Injectable GHK-Cu requires reconstitution from lyophilized powder with bacteriostatic water. This route delivers the peptide systemically rather than locally. However, injectable GHK-Cu is currently restricted under FDA Category 2, meaning compounding pharmacies cannot legally produce it at this time. Topical formulations are unaffected by this restriction.
For detailed protocols including reconstitution steps, injection technique, and cycling recommendations, see our GHK-Cu dosage guide. For combination protocols, see the GHK-Cu + BPC-157 + TB-500 GLOW Stack guide.
AHK-Cu
AHK-Cu is used exclusively as a topical product:
Topical (only route): Applied to the scalp via serums, solutions, or leave-in treatments. Commercial formulations typically contain AHK-Cu at concentrations of 100-500 ppm (parts per million). Application is usually once daily to clean, dry scalp, massaged into areas of thinning.
AHK-Cu is not available in injectable form and has no established injection protocols. It does not require reconstitution — it is used as a finished cosmetic product applied directly to the scalp or skin. This makes it the more accessible of the two peptides for people who prefer a non-invasive, no-injection approach.
Some skincare formulations also include AHK-Cu for facial application, though this use is less common and less studied than GHK-Cu for skin-specific outcomes.
GHK-Cu vs AHK-Cu: Head-to-Head Comparison
| Feature | GHK-Cu | AHK-Cu |
|---|---|---|
| Full name | Copper Tripeptide-1 | Copper Tripeptide-3 |
| Amino acid sequence | Gly-His-Lys + Cu²⁺ | Ala-His-Lys + Cu²⁺ |
| Origin | Naturally occurring (human plasma) | Synthetic (lab-designed) |
| Primary use | Skin, wound healing, anti-aging | Hair growth, scalp health |
| Mechanism breadth | Broad (4,000+ genes, multiple tissues) | Targeted (dermal papilla cells, hair cycle) |
| Research depth | Extensive (hundreds of studies since 1970s) | Limited (handful of studies since 2007) |
| Administration routes | Topical + Injectable | Topical only |
| Injectable available | Yes (currently FDA Category 2) | No |
| Regulatory status | Topical: unrestricted / Injectable: restricted | Cosmetic ingredient (unrestricted) |
| Typical products | Serums, creams, injectable vials | Hair serums, scalp treatments |
| Key growth factor | Multiple (collagen, elastin, GAGs, SOD) | VEGF (vascular endothelial growth factor) |
| Key suppression | MMPs, NF-kB, pro-inflammatory cytokines | TGF-beta1, caspase-3 |
For a comparison of GHK-Cu against its non-copper-bound form, see our GHK vs GHK-Cu comparison.
Which Should You Choose?
Choose GHK-Cu if:
- Your primary goal is skin rejuvenation or anti-aging. GHK-Cu has the strongest evidence base for improving skin firmness, reducing fine lines, and increasing collagen density. It is the gold standard copper peptide for skin.
- You are dealing with wound healing or tissue repair. GHK-Cu's broad tissue-remodeling effects make it the better choice for post-procedure recovery, scar reduction, or general tissue repair.
- You want a broadly researched peptide with systemic effects. GHK-Cu influences thousands of genes across multiple tissue types. Its effects extend well beyond any single application.
- You are interested in injectable protocols. GHK-Cu is the only copper peptide with established injection protocols (when legally available through compounding pharmacies).
- You are addressing photodamage or chronic skin inflammation. GHK-Cu's antioxidant (SOD, Nrf2) and anti-inflammatory (NF-kB) mechanisms directly target the pathways that drive sun damage and inflammaging.
Choose AHK-Cu if:
- Your primary goal is hair growth or slowing hair thinning. AHK-Cu was specifically designed to target the cells that control the hair growth cycle. Its mechanism is more directly relevant to hair than GHK-Cu's indirect support.
- You want to target dermal papilla cells directly. AHK-Cu's effects on DPC proliferation, VEGF production, and TGF-beta1 suppression are specific to the follicular microenvironment.
- You prefer a topical-only, non-invasive approach. AHK-Cu does not require injections, reconstitution, or cycling. It is applied as a simple scalp serum.
- You are specifically addressing androgenetic alopecia. AHK-Cu's anti-apoptotic effects on DPCs (Bcl-2/Bax ratio, caspase-3 reduction) are relevant to the follicle miniaturization that drives pattern hair loss.
Consider using both if:
- You want comprehensive copper peptide coverage for both skin and hair. GHK-Cu for facial skin and AHK-Cu for the scalp is a common combination. They target different cell populations through different mechanisms, so there is no redundancy.
- You are addressing both thinning hair and aging skin simultaneously. Many people over 40 are dealing with both concerns. Using GHK-Cu topically on the face and AHK-Cu topically on the scalp addresses both without interference.
Safety and Side Effects
Both copper peptides have favorable safety profiles in topical use:
GHK-Cu is well-tolerated topically with no significant adverse effects reported in published clinical studies. Injectable administration may cause mild injection site redness or irritation that typically resolves within hours. Allergic reactions are rare but possible.
AHK-Cu has no significant adverse effects reported in the published literature. As a topical cosmetic ingredient, it has been used commercially without notable safety signals.
Important considerations for both peptides:
- Do not combine with strong acids. High-concentration AHAs (glycolic acid), BHAs (salicylic acid), or L-ascorbic acid (vitamin C) can destabilize the copper-peptide bond, reducing efficacy. If using both copper peptides and acid-based products, apply them at different times of day.
- Do not apply to fresh open wounds. While GHK-Cu supports wound healing in the remodeling phase, copper peptides should not be applied during the initial inflammatory phase of an open wound. Wait until the wound has closed before introducing copper peptide products.
- Patch test first. As with any active ingredient, apply a small amount to the inner forearm and wait 24 hours before full application to rule out sensitivity.
The Bottom Line
GHK-Cu and AHK-Cu are both copper peptides, but they are not the same product solving the same problem.
GHK-Cu is the established, broadly researched copper peptide. It occurs naturally in the body, modulates thousands of genes, and has decades of published evidence supporting its use for skin rejuvenation, wound healing, and anti-aging. It is the default choice for anyone whose primary concern is skin quality or general tissue health.
AHK-Cu is the engineered specialist. It was designed specifically to stimulate dermal papilla cells and support the hair growth cycle. Its research base is smaller but focused, and it addresses hair thinning through mechanisms that GHK-Cu does not directly target.
They are complementary, not competing. If skin is the priority, use GHK-Cu. If hair is the priority, use AHK-Cu. If both matter, use both — they work through different mechanisms on different cell populations and can be incorporated into the same routine without interference.
PeptideWiki provides educational information about research peptides. This content is not medical advice. Always consult with a qualified healthcare provider before beginning any peptide protocol. See our full disclaimer for details.